<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05617131</url>
  </required_header>
  <id_info>
    <org_study_id>7599</org_study_id>
    <nct_id>NCT05617131</nct_id>
  </id_info>
  <brief_title>Feasibility Study of the Implementation of a Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey</brief_title>
  <acronym>OnKO-TnT-1-0</acronym>
  <official_title>Feasibility Study of the Implementation of a Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      About 2000 cancers/year in France are diagnosed in Adolescents and Young Adults (15-25 years&#xD;
      old, AYA). The cancer plans and the INCA recommend support during and after cancer, taking&#xD;
      into account both medical and psychosocial specificities related to age (supportive care,&#xD;
      school learning/training and professional integration, fertility preservation, therapeutic&#xD;
      education, addictology, sexology...). The care offered is often heterogeneous for these AYAs&#xD;
      in transition between the pediatric and adult worlds. They may be cared for either in&#xD;
      pediatric oncology units or in adult structures. In this context, an AYA team has been&#xD;
      developed in the Strasbourg center, led by a Nurse Coordinator (IDEC), social workers,&#xD;
      psychologists and doctors. Thus, the young patients and their relatives are accompanied by&#xD;
      professionals during their therapeutic care. In spite of this global care and closer to the&#xD;
      patient, it is still necessary to find connected health tools for these AYA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this context, the Strasbourg team has initiated the development of a digital application&#xD;
      compatible for any cell phone OnKO-Tips &amp;Tricks meeting these criteria of necessity. The&#xD;
      application is currently in its final phase and requires validation by patients through a&#xD;
      feasibility study that will last 6 months. Thus, all patients currently followed or newly&#xD;
      diagnosed with liquid or solid cancer and aged between 15 and 25 years old will be included&#xD;
      and will have the opportunity to test the application, its practicality as well as its&#xD;
      current use and in particular its expected benefits for an optimization of our ETP program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collection of the global score of the MAUQ questionnaire (item 1 to 21), filled in by the patients after 6 months of use</measure>
    <time_frame>after 6 months of use</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Solid or Liquid Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subject, whose age is ≥ 15 years and ≤ 25 years, diagnosed at the Strasbourg center (HUS&#xD;
        and ICANS) with solid or liquid cancer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Subject whose age is ≥ 15 years and ≤ 25 years&#xD;
&#xD;
          -  Subject diagnosed at the Strasbourg center (HUS and ICANS) with solid or liquid cancer&#xD;
&#xD;
          -  Subject followed in the Strasbourg center (HUS and ICANS)&#xD;
&#xD;
          -  Subject (or his/her legal representatives) having given his/her (their) agreement to&#xD;
             participate in the evaluation survey of the OnKO-TnT digital application&#xD;
&#xD;
          -  Subject agreeing to complete all satisfaction questionnaires&#xD;
&#xD;
          -  The subject understands, speaks and writes French fluently&#xD;
&#xD;
          -  Subject having a cell phone capable of downloading the application (developed for any&#xD;
             type of cell phone)&#xD;
&#xD;
        Criteria for non-inclusion :&#xD;
&#xD;
          -  Opposition of the subject (or the holders of parental authority) to participate in the&#xD;
             satisfaction survey&#xD;
&#xD;
          -  Subject under legal protection&#xD;
&#xD;
          -  Subject under guardianship or curatorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Natacha ENTZ-WERLE, MD, PhD</last_name>
    <phone>33 3 88 12 83 89</phone>
    <email>natacha.entz-werle@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Strasbourg - France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natacha ENTZ-WERLE, MD, PhD</last_name>
      <phone>33 3 88 12 83 89</phone>
      <email>natacha.entz-werle@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Natacha ENTZ-WERLE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine PAILLARD, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Emmanuel KURTZ, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile SONNTAG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Justine GANTZER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra SPIEGEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra SALMON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Charlotte GAULIER, IDEC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Solid cancer</keyword>
  <keyword>Liquid cancer</keyword>
  <keyword>Connected health tools</keyword>
  <keyword>OnKO-TnT digital application</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

